Il colosso farmaceutico Eli Lilly consolida il suo exploit borsistico in attesa del debutto della pillola anti obesitÃ
Learn more about your ad choices. Visit megaphone.fm/adchoices
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.